Related Experiment Videos
Microinjected Coxsackie B1 virus does not replicate in HEp-2 cells
K R Modalsli1, G Bukholm, S O Mikalsen
1Kapt. W. Wilhelmsen og Frues Bakteriologiske Institutt, University of Oslo, Rikshospitalet, Norway.
Virology
|December 1, 1991
Summary
Coxsackie B1 virus failed to replicate in HEp-2 cells after microinjection. However, viral RNA initiated replication, indicating the virus particle itself was non-infectious in this context.
Area of Science:
- Virology
- Cell Biology
Background:
- Understanding viral replication mechanisms is crucial for developing antiviral strategies.
- HEp-2 cells are a commonly used cell line for studying viral infections.
Purpose of the Study:
- To investigate the replication competence of Coxsackie B1 virus (CVB1) when introduced into HEp-2 cells via microinjection.
- To determine if the viral particle or its RNA is responsible for initiating replication.
Main Methods:
- Microinjection of intact Coxsackie B1 virus particles into HEp-2 cells.
- Microinjection of purified Coxsackie B1 virus RNA into HEp-2 cells.
- Assaying viral replication through measurement of infectious virus particles, viral RNA synthesis, and cell lysis.
Main Results:
- Intact Coxsackie B1 virus particles did not replicate upon microinjection into HEp-2 cells.
- Replication was confirmed by the synthesis of viral RNA and subsequent cell lysis.
- Purified Coxsackie B1 virus RNA, when microinjected, successfully initiated viral replication.
Conclusions:
- The failure of intact CVB1 particles to replicate suggests a potential issue with the virus preparation or its entry/uncoating mechanism within HEp-2 cells under microinjection conditions.
- Viral RNA is the essential component for initiating Coxsackie B1 virus replication in HEp-2 cells.